Olympian Labs DIM-250, 30 Vegetarian Capsules
UPC: 710013001115
Olympian Labs DIM-250 is a dietary supplement formulated to support hormone balance, with diindolylmethane (DIM) derived from cruciferous vegetables like broccoli and cabbage. It includes BioPerine®, a patented black pepper extract from Sabinsa Corporation, which is noted for enhancing nutrient absorption. The 250 mg dosage of DIM is one of three potencies available, alongside 100 mg and 150 mg options, allowing users to select based on individual preference.
Manufactured in a GMP-certified facility in the USA, this product reflects over 30 years of the brand's experience in nutritional supplements. It features a clean formulation with non-GMO, gluten-free, and vegetarian ingredients, encapsulated for convenience. The supplement is designed for daily use, with one capsule taken with a meal, and is free from common allergens such as dairy, soy, and wheat.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| DIM (diindolylmethane) | 250 mg | † |
| BioPerine® (Piper nigrum) | 3 mg | † |
| † Daily Value not established | ||
Other Ingredients
Vegetarian capsule (HPMC), rice flour, microcrystalline cellulose (plant fiber), silicon dioxide, ascorbyl palmitate.
No: Milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, or soybeans.
Certifications & Claims
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
As a dietary supplement, take one (1) capsule daily, or as directed by a healthcare professional.
Warning
If you are pregnant or nursing, have a medical condition, or are taking medication, consult your healthcare professional before using this or any other nutritional supplement. Discontinue use if allergic reaction occurs.Keep out of reach of children. Store in a cool, dry place.
Product Info
- Brand
- Olympian Labs
- UPC
- 710013001115
- Package Qty
- 30 count
- Dimensions
- 4.2 x 2.3 x 2.3 in
- Shipping Weight
- 0.16 lb
- First Available
- 12/2013
